{"id":"https://openalex.org/W168652112","doi":null,"title":"Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.","display_name":"Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.","publication_year":1989,"publication_date":"1989-09-01","ids":{"openalex":"https://openalex.org/W168652112","mag":"168652112","pmid":"https://pubmed.ncbi.nlm.nih.gov/2681004"},"language":"en","primary_location":{"id":"pmid:2681004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2681004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology, therapy, and toxicology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034401100","display_name":"W. Schaumann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"W Schaumann","raw_affiliation_strings":["Medical Research, Boehringer Mannheim GmbH, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research, Boehringer Mannheim GmbH, FRG","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5034401100"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2973,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.42942008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"27","issue":"9","first_page":"445","last_page":"53"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8490999937057495,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8490999937057495,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.0803999975323677,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/isosorbide-dinitrate","display_name":"isosorbide dinitrate","score":1.0},{"id":"https://openalex.org/keywords/isosorbide-mononitrate","display_name":"isosorbide mononitrate","score":0.9670000076293945},{"id":"https://openalex.org/keywords/isosorbide-2-mononitrate","display_name":"isosorbide-2-mononitrate","score":0.9610000252723694},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8349999785423279},{"id":"https://openalex.org/keywords/denitration","display_name":"denitration","score":0.652999997138977},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.6480000019073486},{"id":"https://openalex.org/keywords/total-body-clearance","display_name":"body clearance","score":0.5680000185966492},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9869999885559082},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.8169999718666077},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7540000081062317},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.8399999737739563},{"id":"https://openalex.org/keywords/nitrate","display_name":"nitrate","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C2778949068","wikidata":"https://www.wikidata.org/wiki/Q179748","display_name":"Isosorbide dinitrate","level":2,"score":0.9797732830047607},{"id":"https://openalex.org/C536894130","wikidata":"https://www.wikidata.org/wiki/Q170397","display_name":"Integrated Services Digital Network","level":2,"score":0.671705961227417},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6106528043746948},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5149767994880676},{"id":"https://openalex.org/C2776165368","wikidata":"https://www.wikidata.org/wiki/Q11068","display_name":"Systemic circulation","level":2,"score":0.45193397998809814},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44273319840431213},{"id":"https://openalex.org/C2776915459","wikidata":"https://www.wikidata.org/wiki/Q1243800","display_name":"Isosorbide","level":2,"score":0.4199731647968292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37219029664993286},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2950708270072937},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1814093291759491},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07633912563323975},{"id":"https://openalex.org/C119599485","wikidata":"https://www.wikidata.org/wiki/Q43035","display_name":"Electrical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007548","descriptor_name":"Isosorbide Dinitrate","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007548","descriptor_name":"Isosorbide Dinitrate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:2681004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2681004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology, therapy, and toxicology","raw_type":"Journal Article"},{"id":"mag:168652112","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2681004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W166796609","https://openalex.org/W1996556568","https://openalex.org/W2085794442","https://openalex.org/W217734271","https://openalex.org/W9503787","https://openalex.org/W1912883495","https://openalex.org/W2002609544","https://openalex.org/W1981300184","https://openalex.org/W74101071","https://openalex.org/W199961300"],"abstract_inverted_index":{"Short-acting":[0],"nitrates":[1,15,36],"like":[2],"glyceryl":[3],"trinitrate":[4],"are":[5,56,109,205,218],"most":[6,44],"suitable":[7],"for":[8,16,38,85,89,94,216],"interrupting":[9],"attacks":[10],"of":[11,22,31,66,71,123,130,143,155,161,166,192,202],"angina":[12],"pectoris,":[13],"long-acting":[14],"their":[17,77],"prophylaxis.":[18],"A":[19],"salient":[20],"feature":[21],"drugs":[23],"used":[24],"in":[25],"prophylaxis":[26],"is":[27,47,61,74,82,100],"a":[28],"long":[29],"duration":[30],"action.":[32],"Among":[33],"many":[34],"organic":[35],"developed":[37],"this":[39],"purpose,":[40],"ISDN":[41,46,124,144,194],"became":[42],"the":[43,63,68,72,110,121,133,136,141,149,156,193,196,203],"prominent.":[45],"metabolized":[48,170,206],"to":[49,76,171,174,207],"isosorbide-2-mononitrate":[50],"(IS-2-MN)":[51],"and":[52,91,103,125,135,153,220],"isosorbide-5-mononitrate":[53],"(IS-5-MN)":[54],"which":[55,81,147],"pharmacologically":[57],"active.":[58],"Since":[59],"denitration":[60,69,160],"practically":[62],"only":[64],"way":[65],"elimination,":[67],"rate":[70],"compounds":[73],"proportional":[75],"total":[78,138],"body":[79,139],"clearance,":[80],"3.2":[83],"l/min":[84,88,93],"ISDN,":[86,167],"0.371":[87],"IS-2-MN":[90,217],"0.124":[92],"IS-5-MN.":[95],"Their":[96],"terminal":[97],"elimination":[98],"half-life":[99],"63,":[101],"108":[102],"264":[104],"min":[105],"respectively.":[106],"These":[107],"figures":[108,215],"weighted":[111],"means":[112],"from":[113],"studies":[114],"with":[115],"intravenous":[116,164],"administration.":[117],"Several":[118],"authors":[119],"determined":[120],"AUCs":[122,134],"its":[126],"mononitrates":[127,157],"after":[128,212],"administration":[129,165,187],"ISDN.":[131,162],"From":[132],"respective":[137],"clearances,":[140],"amounts":[142],"were":[145,169],"calculated":[146],"enter":[148,195],"systemic":[150,197],"circulation":[151,198],"intact,":[152],"those":[154],"formed":[158],"by":[159,182],"After":[163,185],"62%":[168],"IS-5-MN,":[172],"24%":[173],"IS-2-MN.":[175],"The":[176,214],"remaining":[177],"14%":[178,219],"must":[179],"be":[180],"eliminated":[181],"other":[183],"routes.":[184],"oral":[186],"as":[188],"plain":[189],"tablets,":[190],"26%":[191],"intact.":[199],"Forty-seven":[200],"percent":[201],"dose":[204],"IS-5-MN":[208],"during":[209],"absorption,":[210],"17%":[211],"absorption.":[213],"5%,":[221],"respectively.(ABSTRACT":[222],"TRUNCATED":[223],"AT":[224],"250":[225],"WORDS)":[226]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}